The ROE as of August 2024 (TTM) for Cerevel Therapeutics Holdings, Inc. (CERE) is -98.94%

According to Cerevel Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -98.94%. This represents a change of 270.69% compared to the average of -26.69% of the last 4 quarters.

Cerevel Therapeutics Holdings, Inc. (CERE) Historical ROE (quarterly & annually)

How has CERE ROE performed in the past?

The mean historical ROE of Cerevel Therapeutics Holdings, Inc. over the last ten years is -129.47%. The current -98.94% ROE has changed -23.58% with respect to the historical average. Over the past ten years (40 quarters), CERE's ROE was at its highest in in the September 2020 quarter at 5.23%. The ROE was at its lowest in in the June 2020 quarter at -622.63%.

Cerevel Therapeutics Holdings, Inc. (CERE) ROE by Quarter and Year

Discovering the peaks and valleys of Cerevel Therapeutics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cerevel Therapeutics Holdings, Inc. (CERE) Average ROE

How has CERE ROE performed in the past?

The current ROE of Cerevel Therapeutics Holdings, Inc. (CERE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cerevel Therapeutics Holdings, Inc. (CERE) ROE vs. Peers

How is CERE’s ROE compared to its peers?

Cerevel Therapeutics Holdings, Inc.’s ROE is greater than Avidity Biosciences, Inc. (-32.89%), greater than Revolution Medicines, Inc. (-34.57%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than SpringWorks Therapeutics, Inc. (-56.13%), greater than Ventyx Biosciences, Inc. (-61.43%), greater than Nuvalent, Inc. (-28.83%), greater than Travere Therapeutics, Inc. (-102.43%), greater than Structure Therapeutics Inc. (-20.15%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Ikena Oncology, Inc. (-42.81%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Apellis Pharmaceuticals, Inc. (-139.02%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Blueprint Medicines Corporation (-85.25%), greater than IGM Biosciences, Inc. (-119.02%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Mineralys Therapeutics, Inc. (-42.61%),

Build a custom stock screener for Cerevel Therapeutics Holdings, Inc. (CERE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerevel Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cerevel Therapeutics Holdings, Inc. (CERE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cerevel Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.